Should I Buy NVDA? NVDA 2026 Analysis

Should You Buy NVIDIA Corp (NVDA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

185.410

1 Day change

7.87%

52 Week Range

212.190

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now (impatient entry): NVDA is trading near key support (S1 ~174.8 / S2 ~169.3) with an oversold short-term RSI, while fundamentals and analyst targets imply meaningful upside from ~$173.
Near-term path: Technical momentum is still bearish, but options positioning and repeated bullish Street commentary suggest dips are being bought; this setup favors an immediate entry rather than waiting for a “perfect” reversal.
Key timing catalyst: Next earnings (QJAN 2026) on 2026-02-25 can re-rate the stock quickly; positioning ahead of that is reasonable given the strong growth trend.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend/Momentum: MACD histogram -1.531 and negatively expanding → downside momentum still active (trend not confirmed as reversed yet).
RSI: RSI_6 20.841 → functionally oversold (despite the label), often associated with short-term snapback potential.
Moving averages: “Converging” MAs → price is compressing; next break can be sharp.
Levels to watch: Pivot 183.641 (regain = improvement). Support S1 174.787 is being tested (current ~$173.4 is slightly below), next support S2 169.316. Resistance R1 192.496.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment (puts vs calls): Put/Call Open Interest = 0.88 and Volume = 0.6 → call-leaning positioning (more bullish than bearish).
Activity: Today’s options volume is ~146% of 30-day average → elevated attention/positioning.
Volatility: 30D IV 49.79 vs historical vol 28.5; IV percentile ~70.9 → options are pricing elevated movement (often seen into catalysts like earnings).
Net take: Options data skews bullish-to-risk-on, consistent with dip-buying rather than panic hedging.

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings catalyst: Next report 2026-02-25 (QJAN 2026) with Street expecting strong results (news cites revenue estimate ~$65.55B and continued bullish stance from major banks).
- Analyst conviction/targets: Multiple firms reiterate Buy/Outperform/Overweight with $235–$275 targets (far above ~$173).
- Strategic positioning: Continued focus on next-gen AI platform ramp (“Vera Rubin” narrative in Street notes) supports longer-duration demand.
- Political/influential flow: Congress trading shows 4 purchases / 0 sales in last 90 days with large disclosed ranges → supportive signal.
- Positioning/tape: Oversold technical condition near support can trigger quick rebounds when broader market stabilizes.

Neutral/Negative Catalysts

- Technical weakness still present: MACD downside expansion implies the stock can still probe lower (next major support ~169).
- Event/regulatory headline risk: News flags AI chip exports to China stalled amid national security reviews and Sen. Warren opposition to a large UAE AI chip sale → potential constraints on certain international revenue channels.
- Supply constraints (gaming): Reported memory chip shortage could delay a new gaming GPU launch (limited impact vs data center, but negative for that segment sentiment).
- Market backdrop: S&P 500 down ~0.99% today adds pressure to high-beta megacaps.

Financial Performance

Latest reported quarter: 2026/Q3
- Revenue: $57.006B, +62.49% YoY (very strong top-line acceleration)
- Net Income: $31.91B, +65.26% YoY (profit growth keeping pace)
- EPS: 1.30, +66.67% YoY
- Gross Margin: 73.56%, -1.92% YoY (slight compression, but still exceptionally high)
Quality of growth: Earnings and revenue are expanding together, indicating the growth is not purely “low-quality” or margin-sacrificing.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Predominantly positive reiterations and price-target raises into 2026.
- Morgan Stanley: Overweight, PT $250 (expects outperformance as share concerns prove overblown; strong checks).
- Mizuho: Outperform, PT raised to $275 from $245 (top pick; sees upside in AI accelerators).
- Citi: Buy, PT $270 (Groq licensing viewed as clear positive).
- Truist: Buy, PT $275 (strategic move to strengthen inference positioning).
- UBS: Buy, PT $235 (expects appreciation driven by higher earnings estimates).
- Wells Fargo: Overweight, PT $265 (next-gen inference push highlighted).
Wall Street pros: Strong AI demand environment, platform leadership, and next-gen product ramp narrative; targets imply large upside vs current price.
Wall Street cons: Headline/regulatory/export uncertainty and near-term stock underperformance/technical pressure, but these are framed mostly as manageable rather than thesis-breaking.

NVDA Should I Buy